Testing traditional Chinese medicine for recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had an ischemic (clot-caused) stroke within the last 48 hours.
- Your stroke caused moderate symptoms, like weakness, confusion, or trouble speaking.
- You do not have bleeding in the brain or other serious health issues (like severe heart, liver, or kidney disease).
- You are willing to take an oral traditional Chinese medicine (pill) and follow study rules, including not donating blood or sperm/eggs for a period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
This study tests a traditional Chinese medicine granule called Xinglou Chengqi. It is for people who had an ischemic stroke (blocked blood vessel in the brain) within the last 7 days and have certain symptoms. The goal is to see if it helps recovery and is safe.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This study tests if connecting smaller hospitals with stroke experts through telemedicine improves treatment for people having an acute ischemic stroke. It may help you get faster, better care if you live in a less populated area.
This trial tests a traditional Chinese medicine (called Angong Niuhuang Wan) for people who have had a bleeding stroke within the last 6 hours. The goal is to see if this medicine helps reduce the damage from the bleed and improves recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.